GoHealth reported a decrease in net revenues to $105.9 million due to a 6% decrease in total submissions. The company experienced a net loss of $59.3 million, an improvement of $10.9 million compared to the prior year period. Despite the revenue decline, GoHealth is intensifying targeted marketing efforts for the upcoming AEP and focusing on technology advancements in AI and automation.
Net revenues for Q2 2024 were $105.9 million, a decrease of $36.9 million compared to the prior year period.
Submissions for Q2 2024 totaled 152,394, a 6% decrease compared to the prior year period.
Net loss for Q2 2024 was $59.3 million, an improvement of $10.9 million compared to the prior year period.
Adjusted EBITDA for Q2 2024 was negative $12.3 million, a decrease of $13.1 million compared to the prior year period.
GoHealth anticipates growth in Submission volume, revenue, and Adjusted EBITDA for the remainder of 2024. The mix of agency versus non-agency agreements will be a key driver of cash flow from operations performance.
Visualization of income flow from segment revenue to net income